Cargando…
Updates on Gene Therapy for Diabetic Retinopathy
PURPOSE OF REVIEW: Diabetic retinopathy (DR), a leading cause of visual impairment in the developed country, is characterized by vascular lesions and neuronal damage of the retina. Treatment options for this condition are currently limited. The advent of therapy targeting vascular endothelial growth...
Autores principales: | Wang, Jiang-Hui, Roberts, Georgina Eloise, Liu, Guei-Sheung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228867/ https://www.ncbi.nlm.nih.gov/pubmed/32415508 http://dx.doi.org/10.1007/s11892-020-01308-w |
Ejemplares similares
-
Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy
por: Gu, Y., et al.
Publicado: (2021) -
Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
por: AlRashidi, Fatimah T., et al.
Publicado: (2018) -
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis
por: McLaughlin, Rene J., et al.
Publicado: (2016) -
Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications
por: Mangialardi, Giuseppe, et al.
Publicado: (2016) -
Artificial Pancreas or Novel Beta-Cell Replacement Therapies: a Race for Optimal Glycemic Control?
por: Nijhoff, Michiel F., et al.
Publicado: (2018)